119 related articles for article (PubMed ID: 22706279)
1. Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia.
Apud JA; Zhang F; Decot H; Bigos KL; Weinberger DR
Am J Psychiatry; 2012 Jul; 169(7):725-34. PubMed ID: 22706279
[TBL] [Abstract][Full Text] [Related]
2. Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status.
Heide J; Zhang F; Bigos KL; Mann SA; Carr VJ; Shannon Weickert C; Green MJ; Weinberger DR; Vandenberg JI
Am J Psychiatry; 2016 Jan; 173(1):53-9. PubMed ID: 26481172
[TBL] [Abstract][Full Text] [Related]
3. Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.
Atalar F; Acuner TT; Cine N; Oncu F; Yesilbursa D; Ozbek U; Turkcan S
Behav Brain Funct; 2010 May; 6():27. PubMed ID: 20507645
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in KCNH2 and a unique hERG isoform in patients with schizophrenia: efficacy-safety link.
Warner B
Am J Psychiatry; 2012 Dec; 169(12):1318; author reply 1318-9. PubMed ID: 23212063
[No Abstract] [Full Text] [Related]
5. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.
Newton-Cheh C; Guo CY; Larson MG; Musone SL; Surti A; Camargo AL; Drake JA; Benjamin EJ; Levy D; D'Agostino RB; Hirschhorn JN; O'donnell CJ
Circulation; 2007 Sep; 116(10):1128-36. PubMed ID: 17709632
[TBL] [Abstract][Full Text] [Related]
6. The KCNH2 gene is associated with neurocognition and the risk of schizophrenia.
Hashimoto R; Ohi K; Yasuda Y; Fukumoto M; Yamamori H; Kamino K; Morihara T; Iwase M; Kazui H; Takeda M
World J Biol Psychiatry; 2013 Mar; 14(2):114-20. PubMed ID: 21936766
[TBL] [Abstract][Full Text] [Related]
7. KCNH2 polymorphism and methadone dosage interact to enhance QT duration.
Hajj A; Ksouda K; Peoc'h K; Curis E; Messali A; Deveaux LL; Bloch V; Prince N; Mouly S; Scherrmann JM; Lépine JP; Laplanche JL; Drici MD; Vorspan F
Drug Alcohol Depend; 2014 Aug; 141():34-8. PubMed ID: 24875677
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology.
Linna EH; Perkiömäki JS; Karsikas M; Seppänen T; Savolainen M; Kesäniemi YA; Mäkikallio T; Huikuri HV
Ann Noninvasive Electrocardiol; 2006 Jan; 11(1):57-62. PubMed ID: 16472284
[TBL] [Abstract][Full Text] [Related]
9. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacogenomic studies on hERG potassium channels.
He FZ; McLeod HL; Zhang W
Trends Mol Med; 2013 Apr; 19(4):227-38. PubMed ID: 23369369
[TBL] [Abstract][Full Text] [Related]
11. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia.
Huffaker SJ; Chen J; Nicodemus KK; Sambataro F; Yang F; Mattay V; Lipska BK; Hyde TM; Song J; Rujescu D; Giegling I; Mayilyan K; Proust MJ; Soghoyan A; Caforio G; Callicott JH; Bertolino A; Meyer-Lindenberg A; Chang J; Ji Y; Egan MF; Goldberg TE; Kleinman JE; Lu B; Weinberger DR
Nat Med; 2009 May; 15(5):509-18. PubMed ID: 19412172
[TBL] [Abstract][Full Text] [Related]
12. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
[TBL] [Abstract][Full Text] [Related]
13. Analysis of
Refisch A; Komatsuzaki S; Ungelenk M; Schumann A; Chung HY; Schilling SS; Jantzen W; Schröder S; Nöthen MM; Mühleisen TW; Hübner CA; Bär KJ
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421807
[TBL] [Abstract][Full Text] [Related]
14. Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: The Finnish Cardiovascular Study.
Koskela J; Laiho J; KäHönen M; Rontu R; Lehtinen R; Viik J; Niemi M; Niemelä K; Kööbi T; Turjanmaa V; Pörsti I; Lehtimäki T; Nieminen T
Scand J Clin Lab Invest; 2008; 68(1):31-8. PubMed ID: 17852802
[TBL] [Abstract][Full Text] [Related]
15. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).
Sinner MF; Pfeufer A; Akyol M; Beckmann BM; Hinterseer M; Wacker A; Perz S; Sauter W; Illig T; Näbauer M; Schmitt C; Wichmann HE; Schömig A; Steinbeck G; Meitinger T; Kääb S
Eur Heart J; 2008 Apr; 29(7):907-14. PubMed ID: 18222980
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
[TBL] [Abstract][Full Text] [Related]
18. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
[TBL] [Abstract][Full Text] [Related]
19. Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.
Ramsey TL; Liu Q; Massey BW; Brennan MD
Schizophr Res; 2013 Sep; 149(1-3):21-5. PubMed ID: 23886675
[TBL] [Abstract][Full Text] [Related]
20. herg1b expression as a potential specific marker in pediatric acute myeloid leukemia patients with HERG 897K/K genotype.
Erdem M; Tekiner TA; Fejzullahu A; Akan G; Anak S; Saribeyoglu ET; Ozbek U; Atalar F
Pediatr Hematol Oncol; 2015 Apr; 32(3):182-92. PubMed ID: 25247487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
